Table 4.

Responses to questions about a future clinical deprescribing trial framework and CONSORT list amendment to include clinical deprescribing trials, based on previous experience in clinical deprescribing trials

Question		Have you previously been involved in clinical deprescribing trials?
		Yes (%)	No (%)
Do you think we need to develop a legal, regulatory, and good clinical practice framework for clinical deprescribing trials?	Yes	61.0	39.0
	No	59.0	41.0
Does the current CONSORT list need to be amended to include clinical deprescribing trials?	Yes	48.6	51.4
	No	29.7	70.3